Published: April 29, 2021 | | |
|
| | Ever wonder why Wall Street always seems to be one step ahead of the average Joe?
It's because insiders have a ton of top-secret trading strategies that give them an edge over everyone else!
And while their methods are usually kept under lock and key… I'm using what I learned as a former hedge fund insider to pull back the curtain on Wall Street's best kept market strategy.
I'm ready to reveal how tracking what I call a "Shadow Blitz" can help everyday traders predict which stocks are set to explode… |
| See How To Use This Discovery | | | |
Lance Ippolito | Lance is a professional trader and a successful entrepreneur with over 10 years of experience in the financial markets. | | |
|
| | | Alternative drug developer Mind Medicine Inc. (Nasdaq: MNMD) debuted on the Nasdaq on Tuesday following an incredible two-day run-up that saw the stock jump over 47%.
MindMed is a biotechnology company focused on the clinical development of psychedelic-sourced drugs.
This is a big win for the alternative pharmaceutical space after years of struggling for mainstream recognition.
The medical and business communities are beginning to realize that treatments like psilocybin mushrooms, ketamine and DMT can help with mental disorders like anxiety, depression and trauma.
According to the Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting 40 million adults. | |
| Here's Why I'm Excited | | | | |
| Russell 2000 Forecast and the 5 Stocks to Target April 26, 2021
A little while ago WealthPress Senior Strategist Roger Scott filmed a Russell 2000 forecast video, and explained how it was beginning to come back to life... Continue Reading | | | How to Play Tesla — or Any — Earnings With Limited Risk April 26, 2021
When implied volatility picks up the way it does around earnings events, it offers traders the opportunity to take advantage of it if they know how... Continue Reading | | |
0 Response to "MindMed’s Nasdaq Debut a Win for Alternative Medicine. Is It a Buy?"
Post a Comment